Hypocalcaemia after inpatient injectables for hip fracture patients: lessons learnt from an orthogeriatric rehab unit
Introduction: The Five Nations Consensus (2023) recommends inpatient intravenous zoledronate for secondary prevention following hip fracture.1 Denosumab is an alternative in patients who are unable to receive bisphosphonates. Post-injectable hypocalcaemia is a recognised side effect of either therap...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-07-01
|
| Series: | Clinical Medicine |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1470211825001277 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|